CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 120 filers reported holding CYMABAY THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $648,000 | -27.6% | 142,800 | -8.4% | 0.00% | -100.0% |
| Q4 2020 | $895,000 | -22.2% | 155,965 | -1.8% | 0.00% | 0.0% |
| Q3 2020 | $1,150,000 | +115.0% | 158,865 | +3.6% | 0.00% | 0.0% |
| Q2 2020 | $535,000 | +274.1% | 153,365 | +59.1% | 0.00% | – |
| Q1 2020 | $143,000 | -24.3% | 96,400 | 0.0% | 0.00% | – |
| Q4 2019 | $189,000 | +80.0% | 96,400 | +368.0% | 0.00% | – |
| Q3 2019 | $105,000 | -25.0% | 20,600 | +5.0% | 0.00% | – |
| Q2 2019 | $140,000 | -61.3% | 19,618 | -57.4% | 0.00% | -100.0% |
| Q4 2018 | $362,000 | -40.0% | 46,028 | -15.4% | 0.00% | 0.0% |
| Q3 2018 | $603,000 | +25.1% | 54,420 | +46.7% | 0.00% | 0.0% |
| Q1 2018 | $482,000 | -1.0% | 37,096 | -29.9% | 0.00% | 0.0% |
| Q4 2017 | $487,000 | – | 52,932 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $11,887,000 | 8.85% |
| Foresite Capital Management IV, LLC | 1,787,094 | $12,939,000 | 2.92% |
| Copernicus Capital Management, LLC | 278,416 | $2,016,000 | 1.92% |
| Sio Capital Management, LLC | 1,159,236 | $8,393,000 | 1.66% |
| ACUTA CAPITAL PARTNERS, LLC | 765,000 | $5,539,000 | 1.50% |
| Avoro Capital Advisors LLC | 10,300,000 | $74,572,000 | 1.06% |
| Boxer Capital, LLC | 4,000,000 | $28,960,000 | 1.00% |
| Vivo Capital, LLC | 2,089,356 | $15,127,000 | 0.87% |
| EAM Global Investors LLC | 284,534 | $2,060,000 | 0.76% |
| Versant Venture Management, LLC | 543,753 | $3,937,000 | 0.72% |